Dynamic cells linked to brain tumor growth and recurrence

In mice, researchers have discovered the presence of oncostreams, highly active cells connected to how brain tumors grow and invade healthy tissue.

8:11 AM

Author | Anna Megdell

microscopic collagen tumor green blue
Collagen 1, a protein produced by tumor cells, is essential to the growth and function of these tumor oncostreams. Image courtesy of Pedro Lowenstein

Tumors are made up of many types of cells, both cancerous and benign. The specific complexity of the cells inside brain tumors has been a trademark of the disease, one that makes treatment extremely difficult. While scientists have long known about the variety of cells within a brain tumor, the ways these tumors grow has relied on the understanding that the cells are static, unmoving and relatively fixed.

But researchers at the University of Michigan Department of Neurosurgery and Rogel Cancer Center have discovered that these aggressive tumors contain highly active cells that move throughout tissue in complicated patterns. What's more, the accumulations of these elongated, spindle-like cells found throughout the tumor, coined 'oncostreams,' serve as the basis for cancerous cells' behavior, determining how tumors grow and invade normal tissue.

Pedro Lowenstein, M.D., Ph.D., Richard C. Schneider Collegiate Professor of Neurosurgery and lead author of this study in Nature Communications, says this organized growth is what makes brain tumors so relentless.

"Brain tumors are highly lethal, with less than 5% of patients living beyond five years," he said. "Unfortunately, reoccurrence is what eventually kills patients. They receive surgery for their initial tumor, but the tumor always comes back within 12 to 18 months," he said.  

Lowenstein and his team, including Maria Castro, Ph.D., also found that overexpression of Collagen 1, a protein produced by tumor cells, is essential to the growth and function of these structures.

"When we eliminated Collagen 1 production from tumor cells, the animal models with brain tumors lived much longer. This step removes oncostreams from tumors and reduces tumor aggressive behavior because the tumors need Collagen 1 to move in the specific way we discovered," said Lowenstein.

Lowenstein says this structure is likely present in other types of cancer, too. "Once people recognize that there are dynamic areas of the tumor, and that they're related to tumor growth, eventual invasion and death, people will likely locate oncostreams in other tumor models," he said.

To detect this previously unknown presence of oncostreams, the team collaborated with Todd Hollon, M.D., assistant professor in the Michigan Medicine Department of Neurological Surgery, and Sebastien Motsch, Ph.D., associate professor of mathematics at Arizona State University, to implement artificial intelligence methods to identify the structures in tissue.

"Essentially, we showed images to a computer and the computer eventually learns to recognize oncostreams," Lowenstein explained.

Dismantling oncostreams through the removal of Collagen 1 could represent a novel therapeutic target to treat lethal brain tumors. "This research proves the crucial importance of continuing to investigate the complicated extracellular matrix," notes Andrea Comba, Ph.D., research investigator and first author of the study.

"Based on this discovery, we propose targeting tumor collagen to disrupt oncostreams, and as novel therapy for the treatment of brain glioma," she said.

Paper cited: "Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression," Nature Communications. DOI: 10.1038/s41467-022-31340-1

Funding: National Institutes of Health, National Institute of Neurological Disorders and Stroke grants (R37-NS094804, R01-NS105556, R21-NS107894, R21-NS091555, R01-NS074387); National Institute of Neurological Disorders and Stroke grants (R01-NS076991, R01-NS096756, R01-NS082311, R01-NS122234, R01-NS127378); National Institute of Biomedical Imaging and Bioengineering (R01-EB022563); National Cancer Institute (U01CA224160); Rogel Cancer Center at The University of Michigan (G023089); Ian's Friends Foundation grant (G024230); Leah's Happy Hearts Foundation grant (G013908); Pediatric Brain Tumor Foundation grant (G023387); ChadTough Foundation grant (G023419); RNA Biomedicine grant (F046166); National Cancer Institute grants: (R01 CA125577, R01 CA107469); Health and Human Services; National Institutes of Health ( UL1 TR002240); Michigan Institute for Clinical and Health Research; Postdoctoral Translational Scholars Program (Project F049768.)


More Articles About:

Lab Report All Research Topics Neurology Neurosurgery & Neurological Procedures Brain Cancer Cancer: Help, Diagnosis & Treatment Cancer: Cancer Types
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Man sits in a medical exam room looking at caregiver whose back is to camera and looks toward a computer screen.
Health Lab

Updated prostate cancer screening guidelines emphasize benefits of early detection

New guidelines for prostate cancer screening focus on early detection and individual risk.
Mother sits on a couch with a laptop on her lap while an elementary school age boy sits next to her playing on a tablet device.
Health Lab

New questionnaire aims to improve understanding of demand avoidance in children, teens

Pathological demand avoidance is a pattern of intense distress and avoidance of demands in children. A new questionnaire from University of Michigan researchers creates a structured way to assess these behaviors.
Blue round cells in three pictures showing how they change under stress.
Health Lab

Timing is of the essence for RNA during stress

Key determiners of which RNA can be read to make proteins is time. Previous thinking was that a cell under threat would quickly make these RNAs in the nucleus and immediately push them into the cytoplasm.
Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
Rachel Upjohn Building groundbreaking ceremony
News Release

How U-M helped bring depression out of the darkness

The history of the founding of the Eisenberg Family Depression Center at the University of Michigan, the nation's first center focused on research, community outreach and stigma reduction in depression and bipolar disorder.